IP Library Granted Patent US 10,976,312
Granted Patent B2
US 10,976,312 · App. 15/402,879 · Granted Apr 13, 2021

Compositions and methods for capture of cellular targets of bioactive agents

Inventors: Carolyn W. Hitko (Grover Beach, CA); Robin Hurst (Madison, WI); Thomas Kirkland (Atascadero, CA); Dieter Klaubert (Arroyo Grande, CA); Poncho Meisenheimer (San Luis Obispo, CA); Nidhi Nath (Madison, WI); Rachel Friedman Ohana (Madison, WI); Paul Otto (Madison, WI); Marjeta Urh (Madison, WI); Harry Tetsuo Uyeda (Los Osos, CA); Keith Wood (Mt. Horeb, WI); Ji Zhu (Croton on Hudson, NY)
Assignee: Promega Corporation
G01N33/54333G01N33/54306G01N33/54326
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,976,312
App. No.
15/402,879
Granted
Apr 13, 2021
Kind
B2
Abstract

The present invention provides compositions and methods for capture and identification of the cellular targets of a bioactive agent. In particular, provided herein are bioactive agents tethered to capture ligand, cellular targets (optionally tagged with a reporter), capture proteins (optionally present as capture fusions), surfaces (e.g., displaying, capture ligands, capture proteins, or capture fusions), and methods of capturing and identifying the cellular targets of a bioactive agent therewith.

Claims (11)

1. A composition comprising:

(a) lysed cells comprising a cellular target of a small molecule bioactive agent;

(b) the small molecule bioactive agent tethered to a chloroalkane capture ligand, wherein the small molecule bioactive agent is capable of non-covalently binding to the cellular target; and

(c) a solid surface displaying a dehalogenase capture protein, wherein the dehalogenase capture protein is capable of forming a covalent bond with the chloroalkane capture ligand upon interaction thereof.

2. The composition of claim 1 , wherein the cellular target is a fusion with a reporter protein.

3. The composition of claim 2 , wherein the reporter protein is a bioluminescent reporter.

4. The composition of claim 3 , wherein the bioluminescent reporter comprises a polypeptide with at least 70% sequence identity with SEQ ID NO.: 3.

5. The composition of claim 1 , wherein the dehalogenase capture protein comprises at least 70% sequence identity with SEQ ID NO.: 1.

6. The composition of claim 1 , wherein the solid surface is selected from the group consisting of well, tube, slide, plate, matrix, resin and bead.

7. The composition of claim 6 , wherein the solid surface is magnetic or paramagnetic.

8. The composition of claim 1 , wherein the cellular target is bound to the small molecule bioactive agent, and the capture protein is bound to the capture ligand.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2017
From: HITKO, CAROLYN W.; HURST, ROBIN; KIRKLAND, THOMAS; KLAUBERT, DIETER; MEISENHEIMER, PONCHO; NATH, NIDHI; OHANA, RACHEL FRIEDMAN; OTTO, PAUL; URH, MARJETA; UYEDA, HARRY TETSUO; WOOD, KEITH; ZHU, JI
To: PROMEGA CORPORATION
Reel/Frame 040952/0675 →